Developing Social Listening


Developing social listening programs for pharmaceutical companies

Pharmaceutical companies aren't currently taking full advantage of the wealth of patient-generated content on social media channels. Here, Deloitte's Becca Ramble and Katy Balatero outline how these companies can set up successful social listening programs to uncover patient insights while managing and mitigating risk.

Developing social listening programs for pharmaceutical companies

Social networks and online communities play an important role in consumer health management, serving as hubs where patients and caregivers meet to ask questions, share information, and compare experiences with treatments and medications. The Deloitte Center for Health Solutions “2015 Survey of US Health Care Consumers” found that 52 percent of consumers actively search online for health- or care-related information. Patient-generated content on these digital platforms can illustrate the needs, wants, motivations, behaviors, and decision considerations of patients, caregivers, and healthcare providers. This data can provide a valuable source of insights for pharmaceutical companies seeking to understand how best to reach, engage, and support patients and healthcare providers across the patient journey.

Please find on your right the link back to the original post where the article was first published.

Fanden Sie diese Information hilfreich?